Cencora, Inc. COR

306.92 (2.95) (0.95%) as of 25 Sep
Market cap
$59.1B
P/E
22.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Cencora, Inc. (COR) EV/EBITDA

As of 25 September 2026, Cencora, Inc. (COR) trades at a EV/EBITDA of 16.6×. Over the past ten years it has ranged from 0.0× (September 2021) to 334× (April 2015); the current reading is higher than 79% of that period. That is above the Medical Distribution industry median of 15.5× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 17.3× 23.91%
FY2024 13.9× 20.43%
FY2023 11.6× 16.68%
FY2022 9.9× 0.18%
FY2021 9.9× —
FY2020 0.0× —
FY2019 11.4× 2.95%
FY2018 11.1× (15.11%)
FY2017 13.1× 33.17%
FY2016 9.8× (70.04%)

Quarterly

Period EV/EBITDA Change
Jun 2026 15.5× (16.75%)
Mar 2026 18.6× (3.35%)
Dec 2025 19.2× 11.23%
Sep 2025 17.3× 2.95%
42 more quarters

Against its own ten years

Low 0.0× High 334×
Ten-year median 12.6×
Current reading's percentile 79

EV/EBITDA against peers

Company EV/EBITDA
COSM Cosmos Health Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
YI 111, Inc. Sponsored ADR compare n/m
ACH Accendra Health, Inc. compare 8.2×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation compare 15.5×
CAH Cardinal Health, Inc. compare 15.7×
COR Cencora, Inc. 16.6×
Medical Distribution industry median 15.5×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on COR